Physician profile
Maryam Awan
NPI 1932387578
$749.28
in general payments reported to CMS, 2019-2025
16 companies · $15.20 in 2025
The $15.20 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $92.02 · 2021: $168 · 2022: $179 · 2023: $41.18 · 2024: $98.15 · 2025: $15.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $271.84 | 2019-2022 | |
| Hologic Sales and Service, LLC | $78.55 | 2021-2024 | Aptima |
| Astellas Pharma US INC | $72.75 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $41.48 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $40.85 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $40.61 | 2021 | |
| Scynexis, INC. | $40.35 | 2022 | |
| Lupin INC. | $33.37 | 2019 | |
| Sumitomo Pharma America, INC. | $21.76 | 2024 | Myfembree |
| Organon LLC | $19.53 | 2021 | |
| Ge Healthcare | $18.20 | 2022 | |
| Myovant Sciences INC. | $17.15 | 2021 | |
| Pfizer INC. | $15.59 | 2022 | |
| Millicent US INC | $13.16 | 2019 | |
| Allergan, INC. | $12.14 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryam Awan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.